Suanfarma Suanfarma

X

Find Esaxerenone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Esaxerenone
Also known as: 1632006-28-0, Cs-3150, Esaxerenone [inn], Xl-550, N62tgj04a1, 1-(2-hydroxyethyl)-4-methyl-n-(4-methylsulfonylphenyl)-5-[2-(trifluoromethyl)phenyl]pyrrole-3-carboxamide
Molecular Formula
C22H21F3N2O4S
Molecular Weight
466.5  g/mol
InChI Key
NOSNHVJANRODGR-UHFFFAOYSA-N
FDA UNII
N62TGJ04A1

Esaxerenone is under investigation in clinical trial NCT02722265 (Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension).
1 2D Structure

Esaxerenone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(2-hydroxyethyl)-4-methyl-N-(4-methylsulfonylphenyl)-5-[2-(trifluoromethyl)phenyl]pyrrole-3-carboxamide
2.1.2 InChI
InChI=1S/C22H21F3N2O4S/c1-14-18(21(29)26-15-7-9-16(10-8-15)32(2,30)31)13-27(11-12-28)20(14)17-5-3-4-6-19(17)22(23,24)25/h3-10,13,28H,11-12H2,1-2H3,(H,26,29)
2.1.3 InChI Key
NOSNHVJANRODGR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(N(C=C1C(=O)NC2=CC=C(C=C2)S(=O)(=O)C)CCO)C3=CC=CC=C3C(F)(F)F
2.2 Other Identifiers
2.2.1 UNII
N62TGJ04A1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(2-hydroxyethyl)-4-methyl-n-(4-(methylsulfonyl)phenyl)-5-(2-(trifluoromethyl)phenyl)-1h-pyrrole-3-carboxamide

2. Cs-3150

2.3.2 Depositor-Supplied Synonyms

1. 1632006-28-0

2. Cs-3150

3. Esaxerenone [inn]

4. Xl-550

5. N62tgj04a1

6. 1-(2-hydroxyethyl)-4-methyl-n-(4-methylsulfonylphenyl)-5-[2-(trifluoromethyl)phenyl]pyrrole-3-carboxamide

7. Unii-n62tgj04a1

8. 1-(2-hydroxyethyl)-4-methyl-n-(4-(methylsulfonyl)phenyl)-5-(2-(trifluoromethyl)phenyl)-1h-pyrrole-3-carboxamide

9. Chembl2181932

10. 1h-pyrrole-3-carboxamide, 1-(2-hydroxyethyl)-4-methyl-n-(4-(methylsulfonyl)phenyl)-5-(2-(trifluoromethyl)phenyl)-, (5s)-

11. E6r

12. Esaxerenone (jan/inn)

13. Esaxerenone [jan]

14. Esaxerenone [who-dd]

15. Gtpl9894

16. Schembl1381714

17. Dtxsid601336896

18. Glxc-26595

19. Ex-a2595

20. Bdbm50398059

21. Cs-3150 (esaxerenone;xl-550)

22. Akos032946523

23. Cs-8044

24. Db15207

25. Cs-3150; Xl-550

26. Ac-36169

27. Ms-28595

28. Hy-100471

29. A16925

30. D10892

31. Q27284603

32. (+/-)-1-(2-hydroxyethyl)-4-methyl-n-[4-(methylsulfonyl)phenyl]-5-[2-(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide

33. 1-(2-hydroxyethyl)-n-(4-methanesulfonylphenyl)-4-methyl-5-[2-(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide

34. 880780-76-7

2.4 Create Date
2008-11-24
3 Chemical and Physical Properties
Molecular Weight 466.5 g/mol
Molecular Formula C22H21F3N2O4S
XLogP32.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area96.8
Heavy Atom Count32
Formal Charge0
Complexity747
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY